Discovery of Highly Potent, Selective, and Efficacious Small Molecule Inhibitors of ERK1/2
作者:Li Ren、Jonas Grina、David Moreno、James F. Blake、John J. Gaudino、Rustam Garrey、Andrew T. Metcalf、Michael Burkard、Matthew Martinson、Kevin Rasor、Huifen Chen、Brian Dean、Stephen E. Gould、Patricia Pacheco、Sheerin Shahidi-Latham、Jianping Yin、Kristina West、Weiru Wang、John G. Moffat、Jacob B. Schwarz
DOI:10.1021/jm501921k
日期:2015.2.26
Using structure-based design, a novel series of pyridone ERK1/2 inhibitors was developed. Optimization led to the identification of (S)-14k, a potent, selective, and orally bioavailable agent that inhibited tumor growth in mouse xenograft models. On the basis of its in vivo efficacy and preliminary safety profiles, (S)-14k was selected for further preclinical evaluation.